Annika Beer, Doktorandin
Larglinda Islami, Doktorandin
Florian König, TA
Verena Könning, TA
Dr. Inigo Ruiz de Azua, Wissenschaftler
Dr. Margaryta Tevosian, Postdoktorandin
Constance Vennin, Postdoktorandin
Die Arbeitsgruppe untersucht die Bedeutung des Endocannabinoid-Systems als Mediator von Stressresilienz. Hierzu wird dieses neuromodulatorische System mittels genetischer, epigenetischer und pharmakologischer Methoden in Mäusen untersucht. Es werden nicht nur Gehirnfunktionen bezüglich Stressresilienz untersucht, sondern auch periphere neuronale, hormonelle und immunologische Mechanismen. Physische Aktivität kann ebenfalls die Stressantwort und die Resilienz beeinflussen. Die Mechanismen sollen untersucht werden. Es sollen auch Suchtverhalten und Impulskontrolle eingeschlossen werden, und die Frage untersucht werden, warum nur ein geringer Teil der Tiere trotz Exposition z.B. zu appetitsteigerndem Futter die Kontrolle über das Essverhalten verlieren.
- Transkriptionale Netzwerkanalysen in Stressresilienz mittels Einzelzell-Sequenzierungen in ausgewählten neuralen Zellpopulationen in der Maus
- Signalmediatoren im Blut zur Vermittlung von trainingsinduzierter Stressresilienz
- Endocannabinoide in der Vermittlung der Stressresilienz
- Kartierung aktivierter Gehirnregionen in Stressresilienz
- Prof. Dr. Rafael Maldonado, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spanien
- Prof. Dr. Hans-Christian Pape, Institut für Physiologie, Universitätsmedizin Münster
- DFG
- Boehringer Ingelheim Stiftung
Navandar M, Elena Martín-García E, Maldonado R, Lutz B, Gerber S#, Ruiz de Azua I# (2021). Transcriptomic signatures in prefrontal cortex confer vulnerability versus resilience to food and cocaine addiction-like behavior in mouse. Scientific Reports 11(1):9076.
>> Link zu PubmedPreuss UW, Huestis MA, Schneider M, Hermann D, Lutz B, Hasan A, Kambeitz J, Wong JWM, Hoch E (2021). Cannabis Use and Car Crashes: A Review. Front Psychiatry 12:643315.
>> Link zu PubmedRuiz de Azua I*, Martin-Garcia E*, Domingo-Rodriguez L, Aparisi Rey A, Pascual Cuadrado D, Islami L, Turunen P, Remmers F, Lutz B#, Maldonado R# (2021). Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons drives overconsumption of palatable food and obesity. Neuropsychopharmacol 46(5):982-991. (*equal contribution, # shared senior authorship)
>> Link zu PubmedLeschik J, Lutz B, Gentile A (2021). Stress-Related Dysfunction of Adult Hippocampal Neurogenesis-An Attempt for Understanding Resilience? Int J Mol Sci 22(14):7339.
>> Link zu PubmedDomingo-Rodriguez L, Ruiz de Azua I, Dominguez E, Senabre E, Serra I, Kummer S, Navandar M, Baddenhausen S, Hofmann C, Andero R, Gerber S, Navarrete M, Dierssen M, Lutz B, Martín-García E, Maldonado R (2020). A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction. Nat Commun 11:782. doi: 10.1038/s41467-020-14458-y
>> Link zu PubmedJimenez-Blasco D, Busquets-Garcia A, Hebert-Chatelain E, Serrat R, Vicente-Gutierrez C, Ioannidou C, Gómez-Sotres P, Lopez-Fabuel I, Resch-Beusher M, Resel E, Arnouil D, Saraswat D, Varilh M, Cannich A, Julio-Kalajzic F, Bonilla-Del Río I, Almeida A, Puente N, Achicallende S, Lopez-Rodriguez ML, Jollé C, Déglon N, Pellerin L, Josephine C, Bonvento G, Panatier A, Lutz B, Piazza PV, Guzmán M, Bellocchio L, Bouzier-Sore AK, Grandes P, Bolaños JP, Marsicano G (2020) Glucose metabolism links astroglial mitochondria to cannabinoid effects. Nature. 583:603-608. doi: 10.1038/s41586-020-2470-y
>> Link zu PubmedSuárez J, Rivera P, Aparisi Rey A, Pérez-Martín M, Arrabal S, Rodríguez de Fonseca F, Ruiz de Azua I, Lutz B (2019). Adipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impairment in adult neurogenesis. Psychoneuroendocrinology 110:104418. doi: 10.1016/j.psyneuen.2019.104418
>> Link zu PubmedRuiz de Azua I, Lutz B (2019). Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues. Cell Mol Life Sci 76(7):1341-1363. doi: 10.1007/s00018-018-2994-6.
>> Link zu PubmedZimmermann T, Bartsch JC, Beer A, Lomazzo E, Guggenhuber S, Lange MD, Bindila L, Pape HC, Lutz B (2019). Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses. Neuropsychopharmacology 44(8):1377-1388. doi: 10.1038/s41386-018-0274-7
>> Link zu PubmedRivera P, Silva-Peña D, Blanco E, Vargas A, Arrabal S, Serrano A, Pavón FJ, Bindila L, Lutz B, Rodríguez de Fonseca F, Suárez J (2019). Oleoylethanolamide restores alcohol-induced inhibition of neuronal proliferation and microglial activity in striatum. Neuropharmacology 146:184-197. doi: 10.1016/j.neuropharm.2018.11.037.
>> Link zu PubmedZimmermann T, Maroso M, Beer A, Baddenhausen S, Ludewig S, Fan W, Vennin C, Loch S, Berninger B, Hofmann C, Korte M, Soltesz I, Lutz B, Leschik J (2018). Neural stem cell lineage-specific cannabinoid type-1 receptor regulates neurogenesis and plasticity in the adult mouse hippocampus. Cereb Cortex 28(12):4454-4471. doi: 10.1093/cercor/bhy258.
>> Link zu PubmedWickert M, Hildick KL, Baillie GL, Jelinek R, Aparisi Rey A, Monory K, Schneider M, Ross RA, Henley JM, Lutz B (2018). The F238L point mutation in the cannabinoid type 1 receptor enhances basal endocytosis via lipid rafts. Front Mol Neurosci 11:230. doi: 10.3389/fnmol.2018.00230.
>> Link zu PubmedKalisch R, Baker DG, Basten U, Boks MP, Bonanno GA, Brummelman E, Chmitorz A, Fernàndez G, Fiebach CJ, Galatzer-Levy I, Geuze E, Groppa S, Helmreich I, Hendler T, Hermans EJ, Jovanovic T, Kubiak T, Lieb K, Lutz B, Müller MB, Murray RJ, Nievergelt CM, Reif A, Roelofs K, Rutten BPF, Sander D, Schick A, Tüscher O, Diest IV, Harmelen AV, Veer IM, Vermetten E, Vinkers CH, Wager TD, Walter H, Wessa M, Wibral M, Kleim B (2017). The resilience framework as a strategy to combat stress-related disorders. Nat Hum Behav (11):784-790. doi: 10.1038/s41562-017-0200-8.
>> Link zu PubmedLange MD, Daldrup T, Remmers R, Szkudlarek HJ, Lesting J, Guggenhuber G, Ruehle S, Jüngling K, Seidenbecher T, Lutz B, Pape HC (2017). Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat. Mol Psychiatry 22(10):1422-1430.
>> Link zu PubmedRuiz de Azua I, Mancini G, Srivastava RK, Rey AA, Cardinal P, Tedesco L, Zingaretti CM, Sassmann A, Quarta C, Schwitter C, Conrad A, Wettschureck N, Vemuri VK, Makriyannis A, Hartwig J, Mendez-Lago M, Bindila L, Monory K, Giordano A, Cinti S, Marsicano G, Offermanns S, Nisoli E, Pagotto U, Cota D, Lutz B (2017). Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages. J Clin Invest 127:4148-4162. doi: 10.1172/JCI83626
>> Link zu PubmedBusquets-Garcia A, Gomis-González M, Srivastava RK, Cutando L, Ortega-Alvaro A, Ruehle S, Remmers F, Bindila L, Bellocchio L, Marsicano G, Lutz B*, Maldonado R*, Ozaita A* (2016). Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation. Proc Natl Acad Sci USA 113:9904-9. *shared senior authors
>> Link zu PubmedFuss J, Steinle J, Bindila L, Auer MK, Kirchherr H, Lutz B, Gass P (2015). A runner's high depends on cannabinoid receptors in mice. Proc Natl Acad Sci USA 112:13105-13108.
>> Link zu PubmedLomazzo E, Bindila L, Remmers F, Lerner R, Schwitter C, Hoheisel U, Lutz B (2015). Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. Neuropsychopharmacol 40:488-501.
>> Link zu PubmedLutz B, Marsicano G, Maldonado R, Hillard CJ (2015). The endocannabinoid system in gating fear, anxiety and stress. Nat Rev Neurowsci 16:705-718.
>> Link zu Pubmed